NR3C2 and hydrops fetalis: Treatments for HF that have shown efficacy such as angiotensin converting enzyme (ACE) inhibitors, AngII receptor blockers (ARBs), and mineralocorticoid receptor antagonists have shown that their therapeutic effects are in part due to their ability to decrease the development of fibrosis.